Abbott Laboratories (Pakistan) Limited (PSX:ABOT)

Market Cap	89.45B -26.7%
Revenue (ttm)	74.84B +17.3%
Net Income	6.65B +32.9%
EPS	67.93 +33.0%
Shares Out	97.90M
PE Ratio	13.45
Forward PE	11.18
Dividend	10.00 (1.06%)
Ex-Dividend Date	Apr 14, 2025

Volume	5,632
Average Volume	8,278
Open	940.00
Previous Close	945.66
Day's Range	901.08 - 947.97
52-Week Range	790.00 - 1,304.00
Beta	0.09
RSI	25.70
Earnings Date	Feb 20, 2026

About PSX:ABOT

Abbott Laboratories (Pakistan) Limited manufactures, imports, and markets generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products in Pakistan, Afghanistan, Sri Lanka, Bangladesh, and Switzerland. It operates through Pharmaceutical, Nutritional, Diagnostics, and Others segments. The company engages in the manufacturing, importing, and marketing of branded generic pharmaceutical products; AND import and marketing of nutritional products. It imports and markets diagnostic equipment, molecu...

• Industry: Pharmaceuticals
• Sector: Healthcare
• Founded: 1888
• Employees: 1,406
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: ABOT

Financial Performance

In 2024, PSX:ABOT's revenue was 68.18 billion, an increase of 22.90% compared to the previous year's 55.48 billion. Earnings were 5.23 billion, an increase of 1899.50%.